Zephyrnet Logo

Tag: J&J

Top News

Perfuze enrols first patient in stroke trial with its Millipede system

Perfuze has enrolled the first patient in the MARRS pivotal study evaluating the...

Prospera and Greener unite to become Brazil’s first sustainable benefits unicorn.

Together, the companies aim to eliminate energy bills and reduce the carbon footprint of all Brazilians.Sponsored Content. Today is Monday, October 30, 2023.Prospera, a...

Prospera e Greener se unem para se tornar o primeiro unicórnio de benefícios sustentáveis do Brasil.

Juntas, as empresas têm o propósito de zerar a conta de energia e reduzir a pegada de carbono de todos os brasileiros.Conteúdo Patrocinado. Hoje...

How biotech IPOs performed in the third quarter

Initial public offerings may slowly be coming back to the biotechnology sector. Eight biotech companies priced IPOs from July through the end of September, raising...

Here’s what’s moving the needle in biotech stocks, in the final quarter of a dismal year

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good day....

Sept. 28 Quick Takes: FDA approves Amicus’ Pompe disease therapy

ARTICLE | RegulationPlus: J&J’s Rybrevant raises the bar and updates from Harbinger, Gritstone, Merck, Immunovant, Evozyne, PTC   By BioCentury Staff September 29, 2023 12:10 AM UTC FDA Thursday approved late-onset...

FDA lifts hold on Arcellx’s Gilead-partnered cancer cell therapy

Dive Brief: The Food and Drug Administration is allowing biotechnology company Arcellx to resume a clinical trial of a Gilead-partnered cell therapy for multiple myeloma,...

AI Drug Discovery: Key Trends and Developments in Pharmaceutical Industry

AI in Drug Discovery at a Glance The ongoing rise of artificial intelligence (AI) is significantly impacting various industries, with the pharmaceutical and biotech...

Allurion’s Gastric Balloon Landed in Hainan, Facilitated by China Med Device

Allurion’s weight loss gastric balloon completed the first implantation in China at Hainan Ruijin Hospital on June 27, 2023. Overweight patients with a body...

Patient death spurs FDA to pause test of Arcellx’s Gilead-partnered cell therapy

Dive Brief: The Food and Drug Administration has paused a Phase 2 trial of a cell therapy Arcellx is developing for multiple myeloma following the...

GroundUp Studios Launches Creative Council of Producers to Accelerate Web3 Music and Art in Asia

Award-winning producers Derrick Sepnio, Fergus Chow and Jae Chong join Creative Council - with more to come Creative Council's main goal is to...

J&J’s Consumer Spinoff Kenvue Closes Trading At 22% Above Asking Price

Johnson & Johnson’s consumer health spinoff, Kenvue, just solidified its place as the biggest U.S. IPO debut in over a year. Kenvue’s shares...

Latest Intelligence

spot_img
spot_img